NCT04823559

Brief Summary

Background Wales, like other UK countries, has relatively poor cancer outcomes. Late diagnosis and a slow referral process are major contributors. General practitioners (GPs) and other care providers working in primary care are often faced with patients presenting with a multitude of non-specific symptoms that could be cancer. Safety netting can be used to manage diagnostic uncertainty by ensuring patients with vague symptoms are appropriately monitored. The ThinkCancer! Workshop is an educational behaviour change intervention aimed at the whole general medical practice team, designed to improve primary care approaches to ensure timely diagnosis of cancer. The workshop will consist of teaching and awareness sessions, appointment of a Safety Netting Champion and the development of a bespoke Safety Netting Plan. This study aims to assess the feasibility of the ThinkCancer! Intervention for a future definitive randomised controlled trial, in terms of recruitment, randomisation, retention, acceptability, adherence and barriers to the intervention. Methods The ThinkCancer! study is a randomised, multisite feasibility trial, with an embedded process evaluation and economic evaluation. Twenty-three to 30 general medical practices will be recruited across Wales, randomised in a ratio of 2:1 of intervention versus control who will follow usual care. The workshop will be delivered by a GP educator, and will be adapted iteratively throughout the trial period. Baseline practice characteristics will be collected via questionnaire. We will also collect Primary Care Interval (PCI), Two Week Wait (2WW) referral rate, conversion rate and detection rate at baseline and six months post-randomisation. Participant feedback, researcher reflective notes and economic costings will be collected following each workshop. A process evaluation will assess implementation using an adapted Normalisation Measure Development (NoMAD) questionnaire and qualitative interviews. An economic feasibility analysis will inform a future economic evaluation. Discussion This study will allow us to test and further develop a novel evidenced-based complex intervention aimed at general practice teams to expedite the diagnosis of cancer in primary care. The results from this feasibility study will inform the future design of a full-scale definitive phase III trial.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
24

participants targeted

Target at below P25 for not_applicable cancer

Timeline
Completed

Started Feb 2020

Geographic Reach
1 country

7 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 5, 2020

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

December 23, 2020

Completed
3 months until next milestone

First Posted

Study publicly available on registry

April 1, 2021

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2021

Completed
Last Updated

April 1, 2021

Status Verified

March 1, 2021

Enrollment Period

1.5 years

First QC Date

December 23, 2020

Last Update Submit

March 29, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Feasibility of a future definitive trial

    Number of practices approached, interested in participating, consented and randomised, retention of recruited practices, ability to collect data

    From date of initial expression of interest to participate to end of follow up period (13 months)

Secondary Outcomes (2)

  • Two Week Wait referral rate

    Six months pre-randomisation and six months post-randomisation

  • Primary Care Interval

    Six months pre-randomisation and six months post-randomisation

Study Arms (2)

Usual practice

NO INTERVENTION

Usual practice

Intervention

EXPERIMENTAL

Receives educational workshop

Other: ThinkCancer workshop

Interventions

The proposed intervention, the ThinkCancer! Workshop, is practice-based and consists of themed sessions for both clinical and non-clinical staff, the co-production of a Cancer Safety Netting Plan (CSNP) and the appointment of a Cancer Safety Netting Champion (CSNC). The workshop aims to raise awareness and increase knowledge around current cancer diagnosis guidance and will be delivered over half a day during GP protected time in the form of face-to-face educational sessions. Sessions will consist of a series of interactive activities exploring existing processes within practices and developing plans for change to implement each component.

Intervention

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (7)

Betsi Cadwaldr University Health Board

Bangor, United Kingdom

RECRUITING

Aneurin Bevan University Health Board

Blaenau Gwent, United Kingdom

RECRUITING

Hywel Dda University Health Board

Camarthenshire, United Kingdom

RECRUITING

Cardiff and Vale University Health Board

Cardiff, United Kingdom

RECRUITING

Cwm Taf Morgannwg University Health Board

Cwm Taf, United Kingdom

RECRUITING

Powys Teaching Health Board

Powys, United Kingdom

RECRUITING

Swansea Bay University Health Board

Swansea, United Kingdom

RECRUITING

Related Publications (1)

  • Disbeschl S, Surgey A, Roberts JL, Hendry A, Lewis R, Goulden N, Hoare Z, Williams N, Anthony BF, Edwards RT, Law RJ, Hiscock J, Carson-Stevens A, Neal RD, Wilkinson C. Protocol for a feasibility study incorporating a randomised pilot trial with an embedded process evaluation and feasibility economic analysis of ThinkCancer!: a primary care intervention to expedite cancer diagnosis in Wales. Pilot Feasibility Stud. 2021 Apr 21;7(1):100. doi: 10.1186/s40814-021-00834-y.

MeSH Terms

Conditions

Neoplasms

Study Officials

  • Clare Wilkinson

    Bangor University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Jessica L Roberts, BSc, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 23, 2020

First Posted

April 1, 2021

Study Start

February 5, 2020

Primary Completion

August 1, 2021

Study Completion

August 1, 2021

Last Updated

April 1, 2021

Record last verified: 2021-03

Data Sharing

IPD Sharing
Will not share

Locations